“Remote Monitoring of Intranasal Ketamine Self-Administration as Maintenance Therapy in Treatment-Resistant Depression (TRD): A Novel Strategy for Vulnerable and At-Risk Populations to COVID-19?”

Detalles Bibliográficos
Autores principales: Longpré-Poirier, Christophe, Desbeaumes Jodoin, Véronique, Miron, Jean-Philippe, Lespérance, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Geriatric Psychiatry. Published by Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198393/
https://www.ncbi.nlm.nih.gov/pubmed/32446640
http://dx.doi.org/10.1016/j.jagp.2020.04.024
_version_ 1783528973983023104
author Longpré-Poirier, Christophe
Desbeaumes Jodoin, Véronique
Miron, Jean-Philippe
Lespérance, Paul
author_facet Longpré-Poirier, Christophe
Desbeaumes Jodoin, Véronique
Miron, Jean-Philippe
Lespérance, Paul
author_sort Longpré-Poirier, Christophe
collection PubMed
description
format Online
Article
Text
id pubmed-7198393
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Association for Geriatric Psychiatry. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71983932020-05-05 “Remote Monitoring of Intranasal Ketamine Self-Administration as Maintenance Therapy in Treatment-Resistant Depression (TRD): A Novel Strategy for Vulnerable and At-Risk Populations to COVID-19?” Longpré-Poirier, Christophe Desbeaumes Jodoin, Véronique Miron, Jean-Philippe Lespérance, Paul Am J Geriatr Psychiatry Article American Association for Geriatric Psychiatry. Published by Elsevier Inc. 2020-08 2020-05-05 /pmc/articles/PMC7198393/ /pubmed/32446640 http://dx.doi.org/10.1016/j.jagp.2020.04.024 Text en © 2020 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Longpré-Poirier, Christophe
Desbeaumes Jodoin, Véronique
Miron, Jean-Philippe
Lespérance, Paul
“Remote Monitoring of Intranasal Ketamine Self-Administration as Maintenance Therapy in Treatment-Resistant Depression (TRD): A Novel Strategy for Vulnerable and At-Risk Populations to COVID-19?”
title “Remote Monitoring of Intranasal Ketamine Self-Administration as Maintenance Therapy in Treatment-Resistant Depression (TRD): A Novel Strategy for Vulnerable and At-Risk Populations to COVID-19?”
title_full “Remote Monitoring of Intranasal Ketamine Self-Administration as Maintenance Therapy in Treatment-Resistant Depression (TRD): A Novel Strategy for Vulnerable and At-Risk Populations to COVID-19?”
title_fullStr “Remote Monitoring of Intranasal Ketamine Self-Administration as Maintenance Therapy in Treatment-Resistant Depression (TRD): A Novel Strategy for Vulnerable and At-Risk Populations to COVID-19?”
title_full_unstemmed “Remote Monitoring of Intranasal Ketamine Self-Administration as Maintenance Therapy in Treatment-Resistant Depression (TRD): A Novel Strategy for Vulnerable and At-Risk Populations to COVID-19?”
title_short “Remote Monitoring of Intranasal Ketamine Self-Administration as Maintenance Therapy in Treatment-Resistant Depression (TRD): A Novel Strategy for Vulnerable and At-Risk Populations to COVID-19?”
title_sort “remote monitoring of intranasal ketamine self-administration as maintenance therapy in treatment-resistant depression (trd): a novel strategy for vulnerable and at-risk populations to covid-19?”
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198393/
https://www.ncbi.nlm.nih.gov/pubmed/32446640
http://dx.doi.org/10.1016/j.jagp.2020.04.024
work_keys_str_mv AT longprepoirierchristophe remotemonitoringofintranasalketamineselfadministrationasmaintenancetherapyintreatmentresistantdepressiontrdanovelstrategyforvulnerableandatriskpopulationstocovid19
AT desbeaumesjodoinveronique remotemonitoringofintranasalketamineselfadministrationasmaintenancetherapyintreatmentresistantdepressiontrdanovelstrategyforvulnerableandatriskpopulationstocovid19
AT mironjeanphilippe remotemonitoringofintranasalketamineselfadministrationasmaintenancetherapyintreatmentresistantdepressiontrdanovelstrategyforvulnerableandatriskpopulationstocovid19
AT lesperancepaul remotemonitoringofintranasalketamineselfadministrationasmaintenancetherapyintreatmentresistantdepressiontrdanovelstrategyforvulnerableandatriskpopulationstocovid19

Ejemplares similares